{
    "medicine_id": "4741755661612ac69496439904d15ddee22b02ab",
    "platform_id": "DB08874",
    "metadata": {
        "name": "Dificid 200 mg 1 Tablet film coated",
        "composition": "200 mg 1 Fidaxomicin",
        "clinical_particulars": {
            "therapeutic_indications": "Fidaxomicin is indicated for the treatment of _Clostridioides_ formerly _Clostridium_ _difficile_ associated diarrhea in adult and pediatric patients 6 months of age and older L11575 Fidaxomicin should only be used in patients with proven or strongly suspected _C difficile_ infection to reduce the risk of development of drug resistant bacteria and maximize the therapeutic effectiveness of fidaxomicin and other antimicrobial agents L11575",
            "contraindications": {
                "disease": "In rats the LD sub 50 sub of fidaxomicin was approximately 200 mg kg and the no observed adverse effect level NOAEL was determined to be 62 5 mg kg following administration of a single intravenous dose A190489 There is limited clinical data on acute overdose in humans L11575",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Fidaxomicin has a narrow spectrum antibacterial profile with potent bactericidal activity specifically against C difficile A190489 The minimum inhibitory concentration for 90 of organisms for fidaxomicin against _C difficile_ ranged from 0 0078 to 2 \u03bcg mL _in vitro_ A7445 The bactericidal activity of fidaxomicin is time dependent A190492 Other than _C difficile_ fidaxomicin has moderate inhibitory activity against Gram positive bacteria _S aureus_ and _Enterococcus spp _ A190489 and poor activity against normal colonic flora including anaerobes and enteric Gram negative bacilli A190486 Isolates of _C difficile_ that are resistant to rifamycins or other antimicrobial classes such as cephalosporins fluoroquinolones clindamycin were not shown to be cross resistant to fidaxomicin A190486",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Fidaxomicin"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fidaxomicin"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Fidaxomicin"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Fidaxomicin is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Fidaxomicin"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Fidaxomicin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}